How neurosteroid-like drugs work in the brain
Mechanistic studies of Neurosteroid Analogues
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-11158968
Looking at whether new neurosteroid-like drugs can act on specific brain receptors and cell processes to help people with depression.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11158968 on ClinicalTrials.gov |
What this research studies
Researchers at Washington University will use chemically modified neurosteroid compounds to see how they act on key brain receptors and inside cells. They will test effects on GABAA receptors, NMDA receptors, and voltage-gated calcium channels and re-check receptor subtype selectivity in native cells. The team will use tethered ligand approaches to separate membrane-only effects from intracellular actions and will study impacts on inflammatory signals and autophagy pathways. These experiments aim to identify compound features that preserve rapid antidepressant effects while revealing safer or more effective mechanisms.
Who could benefit from this research
Good fit: People with major depressive disorder, especially those interested in rapid-acting treatment options, would be the likely future candidates for trials based on these findings.
Not a fit: Patients who need immediate clinical treatment or whose conditions are unrelated to neurosteroid pathways are unlikely to receive direct benefit from this lab-focused research.
Why it matters
Potential benefit: This work could lead to faster-acting or safer antidepressant drugs that rely on neurosteroid mechanisms.
How similar studies have performed: Related neurosteroid drugs such as brexanolone have produced rapid antidepressant effects in some patients, but the detailed mechanisms remain incompletely understood.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MENNERICK, STEVEN J — WASHINGTON UNIVERSITY
- Study coordinator: MENNERICK, STEVEN J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.